Why Are Clinical Trials of Deep Brain Stimulation Terminated? An Analysis of Clinicaltrials.gov (new Version)
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Unveiling neurocysticercosis: A call for heightened awareness and action.
Okon I, Shafqat M, Shafqat M, Hussain J, Razouqi Y Brain Spine. 2025; 5():104174.
PMID: 39816807 PMC: 11733199. DOI: 10.1016/j.bas.2024.104174.
Microvascular decompression: a contemporary update.
Okon I, Menon S, Osama M, Aiman M, Paleare L, Eliseo 3rd D BMC Surg. 2025; 25(1):20.
PMID: 39794712 PMC: 11724535. DOI: 10.1186/s12893-025-02762-7.
References
1.
Harmsen I, Elias G, Beyn M, Boutet A, Pancholi A, Germann J
. Clinical trials for deep brain stimulation: Current state of affairs. Brain Stimul. 2019; 13(2):378-385.
DOI: 10.1016/j.brs.2019.11.008.
View
2.
Georgiev D, Akram H, Jahanshahi M
. Deep brain stimulation for psychiatric disorders: role of imaging in identifying/confirming DBS targets, predicting, and optimizing outcome and unravelling mechanisms of action. Psychoradiology. 2024; 1(3):118-151.
PMC: 10917192.
DOI: 10.1093/psyrad/kkab012.
View
3.
Rasiah N, Maheshwary R, Kwon C, Bloomstein J, Girgis F
. Complications of Deep Brain Stimulation for Parkinson Disease and Relationship between Micro-electrode tracks and hemorrhage: Systematic Review and Meta-Analysis. World Neurosurg. 2022; 171:e8-e23.
DOI: 10.1016/j.wneu.2022.10.034.
View
4.
Okun M, Vitek J
. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord. 2004; 19(4):375-89.
DOI: 10.1002/mds.20037.
View
5.
Okun M, Tagliati M, Pourfar M, Fernandez H, Rodriguez R, Alterman R
. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005; 62(8):1250-5.
DOI: 10.1001/archneur.62.8.noc40425.
View